Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

TTVR tech used for first time | SCAI wants lead-free cath labs | A big day for Medtronic DCB | Meril TAVR valves after 1 year

News You Need to Know Today
TTVR tech used for first time | SCAI wants lead-free cath labs | A big day for Medtronic DCB | Meril TAVR valves after 1 year
Tuesday, May 27, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Cardiologist shares positive first-in-human data on TriCares TTVR device

The new Topaz TTVR system was associated with the consistent elimination of tricuspid regurgitation. In addition, none of the first 20 patients treated with the device required a permanent pacemaker as a result of the procedure.

READ MORE >
The Topaz transcatheter tricuspid valve replacement (TTVR) system. TriCares GmbH, a global medtech company with offices in France, Germany, the United States and Brazil, has announced the presentation of new first-in-human data on its self-expanding Topaz transcatheter tricuspid valve replacement (TTVR) system. Julien Dreyfus, MD, PhD, a cardiologist with Centre Cardiologique du Nord in France who specializes in tricuspid treatments, presented the findings at EuroPCR in Paris.
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist shares positive first-in-human data on TriCares TTVR device

Share on Twitter Share on Facebook Share on Linkedin
The Topaz transcatheter tricuspid valve replacement (TTVR) system. TriCares GmbH, a global medtech company with offices in France, Germany, the United States and Brazil, has announced the presentation of new first-in-human data on its self-expanding Topaz transcatheter tricuspid valve replacement (TTVR) system. Julien Dreyfus, MD, PhD, a cardiologist with Centre Cardiologique du Nord in France who specializes in tricuspid treatments, presented the findings at EuroPCR in Paris.
The new Topaz TTVR system was associated with the consistent elimination of tricuspid regurgitation. In addition, none of the first 20 patients treated with the device required a permanent pacemaker as a result of the procedure.
READ MORE >

SCAI wants lead-free cath labs and a better work-life balance for cardiologists

"The lead protection we wear is causing a lot of damage," SCAI President Srihari S. Naidu, MD, a veteran interventional cardiologist, explained in an interview.

READ MORE >
Video interview with Hari Naidu SCAI president on the need for policy for increased radiation protection in the cath lab.
Share on Twitter Share on Facebook Share on Linkedin

SCAI wants lead-free cath labs and a better work-life balance for cardiologists

Share on Twitter Share on Facebook Share on Linkedin
Video interview with Hari Naidu SCAI president on the need for policy for increased radiation protection in the cath lab.
"The lead protection we wear is causing a lot of damage," SCAI President Srihari S. Naidu, MD, a veteran interventional cardiologist, explained in an interview.
READ MORE >

Medtronic drug-coated balloon gains multiple new approvals

The Prevail DCB has been cleared to use in dozens of countries around the globe, but it has not yet been approved by the FDA.

READ MORE >
Prevail DCB Medtronic. Medtronic’s Prevail drug-coated balloon (DCB) has received CE mark approval for several new indications related to the treatment of coronary artery disease (CAD). The paclitaxel-coated device, designed to inflate within the patient’s artery during percutaneous coronary intervention (PCI) procedures, is now approved across the EU to treat CAD patients with multivessel disease, acute coronary syndrome and diabetes.
Share on Twitter Share on Facebook Share on Linkedin

Medtronic drug-coated balloon gains multiple new approvals

Share on Twitter Share on Facebook Share on Linkedin
Prevail DCB Medtronic. Medtronic’s Prevail drug-coated balloon (DCB) has received CE mark approval for several new indications related to the treatment of coronary artery disease (CAD). The paclitaxel-coated device, designed to inflate within the patient’s artery during percutaneous coronary intervention (PCI) procedures, is now approved across the EU to treat CAD patients with multivessel disease, acute coronary syndrome and diabetes.
The Prevail DCB has been cleared to use in dozens of countries around the globe, but it has not yet been approved by the FDA.
READ MORE >

Meril TAVR valves linked to 1-year outcomes similar to industry-leading devices from Medtronic, Edwards

Indian medtech company Meril Life Sciences has been manufacturing its Myval TAVR valves for years, but FDA approval has remained out of reach. These latest data represent a one-year update of the multicenter LANDMARK clinical trial.

READ MORE >
cardiologist viewing heart data
Share on Twitter Share on Facebook Share on Linkedin

Meril TAVR valves linked to 1-year outcomes similar to industry-leading devices from Medtronic, Edwards

Share on Twitter Share on Facebook Share on Linkedin
cardiologist viewing heart data
Indian medtech company Meril Life Sciences has been manufacturing its Myval TAVR valves for years, but FDA approval has remained out of reach. These latest data represent a one-year update of the multicenter LANDMARK clinical trial.
READ MORE >

Featured Articles

FDA wants new heart damage warnings added to COVID-19 vaccines

COVID-19 vaccines are associated with a very low risk of myocarditis and/or pericarditis, primarily in young adults. The long-term impact of this risk has been the subject of many studies and debates over the years. One side says that the benefits of vaccination far outweigh the risks, and the other side says that even the smallest risk of heart damage is too high.

READ MORE >
COVID-19 vaccine vaccination myocarditis heart damage inflammation RSNA imaging radiology cardiology
Share on Twitter Share on Facebook Share on Linkedin

FDA wants new heart damage warnings added to COVID-19 vaccines

Share on Twitter Share on Facebook Share on Linkedin
COVID-19 vaccine vaccination myocarditis heart damage inflammation RSNA imaging radiology cardiology
COVID-19 vaccines are associated with a very low risk of myocarditis and/or pericarditis, primarily in young adults. The long-term impact of this risk has been the subject of many studies and debates over the years. One side says that the benefits of vaccination far outweigh the risks, and the other side says that even the smallest risk of heart damage is too high.
READ MORE >

Cardiologists make history, use new robotic imaging system for first time

Researchers believe a new robotic TEE system could improve the long-term health of interventional echocardiographers in addition to several other key benefits.

READ MORE >
ROB’E Robotic transesophageal echocardiography (TEE). ROB’E, a German startup, has developed a new remote-controlled robotic (RCR) system with these challenges in mind. Users are able to remotely manipulate TEE probes, performing precise movements and even saving specific positions so they can be duplicated as needed.
Share on Twitter Share on Facebook Share on Linkedin

Cardiologists make history, use new robotic imaging system for first time

Share on Twitter Share on Facebook Share on Linkedin
ROB’E Robotic transesophageal echocardiography (TEE). ROB’E, a German startup, has developed a new remote-controlled robotic (RCR) system with these challenges in mind. Users are able to remotely manipulate TEE probes, performing precise movements and even saving specific positions so they can be duplicated as needed.
Researchers believe a new robotic TEE system could improve the long-term health of interventional echocardiographers in addition to several other key benefits.
READ MORE >

Work begins on first ATTR-CM study of its kind

ACT-EARLY is testing the hypothesis that treating asymptomatic carriers of a pathogenic TTR variant with the drug acoramidis could delay amyloidosis from developing.

READ MORE >
heart drugs with stethoscope
Share on Twitter Share on Facebook Share on Linkedin

Work begins on first ATTR-CM study of its kind

Share on Twitter Share on Facebook Share on Linkedin
heart drugs with stethoscope
ACT-EARLY is testing the hypothesis that treating asymptomatic carriers of a pathogenic TTR variant with the drug acoramidis could delay amyloidosis from developing.
READ MORE >

Early TAVR or SAVR in asymptomatic patients linked to improved survival, reduced costs

Researchers explored data from more than 24,000 AVR patients, presenting their findings at EuroPCR in Paris.

READ MORE >
cardiologists heart doctors
Share on Twitter Share on Facebook Share on Linkedin

Early TAVR or SAVR in asymptomatic patients linked to improved survival, reduced costs

Share on Twitter Share on Facebook Share on Linkedin
cardiologists heart doctors
Researchers explored data from more than 24,000 AVR patients, presenting their findings at EuroPCR in Paris.
READ MORE >

In Case You Missed It

When valves fail: Surgeons share advice for treating high-risk patients with TAVR explant and SAVR

When a patient’s TAVR valve fails, redo TAVR is not always a feasible option. TAVR explantation and SAVR are typically the answer in these cases, but that approach is associated with certain risks. 

READ MORE >
According to the U.S. government, Asante Health System and one of its surgeons knowingly submitted false claims to Medicare, Medicaid and TRICARE for more than six years. Heart surgery surgeons.
Share on Twitter Share on Facebook Share on Linkedin

When valves fail: Surgeons share advice for treating high-risk patients with TAVR explant and SAVR

Share on Twitter Share on Facebook Share on Linkedin
According to the U.S. government, Asante Health System and one of its surgeons knowingly submitted false claims to Medicare, Medicaid and TRICARE for more than six years. Heart surgery surgeons.
When a patient’s TAVR valve fails, redo TAVR is not always a feasible option. TAVR explantation and SAVR are typically the answer in these cases, but that approach is associated with certain risks. 
READ MORE >

ASNC, ACC ask US government not to tariff radiopharmaceuticals

The two groups stressed that tariffs would likely impact patient care.

READ MORE >
Cardiac SPECT nuclear imaging myocardial perfusion_Spectrum Dynamics_RSNA22_DF_3.jpeg
Share on Twitter Share on Facebook Share on Linkedin

ASNC, ACC ask US government not to tariff radiopharmaceuticals

Share on Twitter Share on Facebook Share on Linkedin
Cardiac SPECT nuclear imaging myocardial perfusion_Spectrum Dynamics_RSNA22_DF_3.jpeg
The two groups stressed that tariffs would likely impact patient care.
READ MORE >

Gastric bypass surgery linked to lower heart attack risk than gastric sleeve

Both operations can help obese patients lose weight, researchers noted, but gastric bypass surgery "may be associated with greater cardiovascular benefits."

READ MORE >
stomach surgery gastric bypass gastric sleeve heart risks
Share on Twitter Share on Facebook Share on Linkedin

Gastric bypass surgery linked to lower heart attack risk than gastric sleeve

Share on Twitter Share on Facebook Share on Linkedin
stomach surgery gastric bypass gastric sleeve heart risks
Both operations can help obese patients lose weight, researchers noted, but gastric bypass surgery "may be associated with greater cardiovascular benefits."
READ MORE >

In Other News

Society of Interventional Radiology joins others in urging Medicare payment for high-cost disposables

The resolution urges the AMA to advocate for separate payment for certain services using supplies priced above $500, as well as those containing high-cost equipment. 

READ MORE >
Interventional radiologist radiology IR genicular artery embolization surgery. Images courtesy of the University of Chicago Medicine
Share on Twitter Share on Facebook Share on Linkedin

Society of Interventional Radiology joins others in urging Medicare payment for high-cost disposables

Share on Twitter Share on Facebook Share on Linkedin
Interventional radiologist radiology IR genicular artery embolization surgery. Images courtesy of the University of Chicago Medicine
The resolution urges the AMA to advocate for separate payment for certain services using supplies priced above $500, as well as those containing high-cost equipment. 
READ MORE >

AI newswatch: OpenAI goes to the UAE, patients get cyberchondria, more

Like remoras hitching a ride on a shark, private businesses are capitalizing on President Trump’s AI-aggressive trip to the Middle East. 

READ MORE >
openAI united arab emirates UAE artificial intelligence
Share on Twitter Share on Facebook Share on Linkedin

AI newswatch: OpenAI goes to the UAE, patients get cyberchondria, more

Share on Twitter Share on Facebook Share on Linkedin
openAI united arab emirates UAE artificial intelligence
Like remoras hitching a ride on a shark, private businesses are capitalizing on President Trump’s AI-aggressive trip to the Middle East. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Week in Review: Star Trek star's family awarded $13M | AI for cardiac amyloidosis | TAVR concerns | New CKM syndrome guidelines
A brand new payment model | Cardiologist compensation keeps rising | Major medtech player invests $1.5B in TAVR tech
Death after TAVR: New data support a change | Rural hospital in spotlight for wrong reason | Heart changes linked to cancer risk
Physicians push back after government report | Device recalled | A lesson for PAD patients | AI for long-term stroke risk
The pros & cons of direct-to-patient drug programs | Why PAD patients should listen to their doctors
Coffee linked to major heart risk | Ablations in ASCs | Catheters recalled | A closer look at PFA | GLP-1 drugs & AFib
New guidelines for cardiovascular-kidney-metabolic syndrome and M-TEER | HF cell therapy company raises $4.4 million

Pagination

    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup